Jeevadravya Bio-Pharma Private Limited
About Jeevadravya Bio-Pharma Private Limited
Data last updated:
Jeevadravya Bio-Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2018PTC178826.
The company has an authorised share capital of ₹324.05 Cr and a paid-up capital of ₹317 Cr. It is led by directors Tushar Vijay Modak and Dattatraya Narayan Dhavalikar.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 16 – B – 1 Dr. Ambedkar Rd Sarosh Bhawan Office – 10, Pune, Maharashtra, India – 411001.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.18 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.07 Cr (net margin -457.5%) and EBITDA of -₹1.97 Cr (EBITDA margin -435.4%).
The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹64 Cr; the latest was in March 2021. Its 10 peer companies in the Healthcare industry (Formulations, Medical and Laboratory Equipment) are compared by revenue, 5 larger and 5 smaller; the largest is D-Cure Pharmaceuticals Private Limited with revenue of ₹45.43 Lakh.
Company details
Contact details
Jeevadravya Bio-Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address16 – B – 1 Dr. Ambedkar Rd Sarosh Bhawan Office – 10, Pune, Maharashtra, India – 411001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jeevadravya Bio-Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jeevadravya Bio-Pharma Private Limited
FY 2025 filings availableJeevadravya Bio-Pharma Private Limited reported revenue of ₹45.18 Lakh (up 3244% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -435.4% | ||||
| Net Profit Margin | -457.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jeevadravya Bio-Pharma Private Limited, buy the company report.
Board of directors of Jeevadravya Bio-Pharma Private Limited
Jeevadravya Bio-Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tushar Vijay Modak | Director | 15 Feb 2020 | 6 Years 8 Months | Current |
| Dattatraya Narayan Dhavalikar Also directs: Magic-Square Hospitality Services LLP, Serene Productions LLP, Poonawalla Biotech Private Limited and 5 more | Director | 19 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Jeevadravya Bio-Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| D-Cure Pharmaceuticals Private Limited | ₹45.43 Lakh (FY 2024) | 16.0% | Delhi, India | |||
| Arcetic Life Sciences Private Limited | ₹45.39 Lakh (FY 2025) | 4185.0% | Pune, Maharashtra, India | |||
| Metaverse Biotech Tools Private Limited | ₹45.39 Lakh (FY 2024) | 703.0% | Mumbai, Maharashtra, India | |||
| Rural Surgery Innovations Private Limited | ₹45.34 Lakh (FY 2024) | -22.0% | Dimapur, Nagaland, India | |||
| Lepidus Pharma India Private Limited | ₹45.31 Lakh (FY 2016) | Hyderabad, Telangana, India | ||||
| Jeevadravya Bio-Pharma Private Limitedthis company | ₹45.18 Lakh (FY 2025) | -₹2.07 Cr | -457.5% | 3244.0% | Pune, Maharashtra, India | |
| Cardea Venture Private Limited | ₹45.12 Lakh (FY 2025) | 5129.0% | Bangalore, Karnataka, India | |||
| Shubhriddhi Lab Services Private Limited | ₹45.11 Lakh (FY 2024) | -72.0% | Nashik, Maharashtra, India | |||
| Schneider Orthopaedic India Private Limited | ₹45.08 Lakh (FY 2019) | -30.0% | Pune, Maharashtra, India | |||
| Bestomed Healthcare Private Limited | ₹45.08 Lakh (FY 2021) | 574.0% | New Delhi, Delhi, India | |||
| Laso Healthcare Private Limited | ₹45 Lakh (FY 2024) | -44.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Jeevadravya Bio-Pharma Private Limited, buy the company report.
Auditor
Jeevadravya Bio-Pharma Private Limited is audited by N V PARASNIS & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N V PARASNIS & CO | FY 2020 | 112857W |
Shareholding
The shareholding of Jeevadravya Bio-Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Jeevadravya Bio-Pharma Private Limited, buy the company report.
Deals & funding
Jeevadravya Bio-Pharma Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹64 Cr; the latest was in March 2021.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Fortune Intercontinental Private Limited Seller: Serum Institute of India Private Limited |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Fortune Intercontinental Private Limited , Chanda Investment and Trading Company Private Limited , Cyza Chem Private Limited Seller: Serum Institute of India Private Limited |
| Mar 2020 | Funding round | ₹64 Cr | Investors: Serum Institute of India Private Limited |
| Feb 2020 | Secondary share transfer | Undisclosed | Buyer: Cyrus Poonawalla Family Trust, an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Jeevadravya Bio-Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jeevadravya Bio-Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jeevadravya Bio-Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jeevadravya Bio-Pharma Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Tushar Vijay Modak ceased to be Additional Director on 15 Dec 2020.
Frequently asked questions
Jeevadravya Bio-Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2018 (8+ years old) and is registered under CIN U24304PN2018PTC178826.
Jeevadravya Bio-Pharma has 2 current directors:
- Tushar Vijay Modak - Director
- Dattatraya Narayan Dhavalikar - Director
The latest financial statements of Jeevadravya Bio-Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Jeevadravya Bio-Pharma is U24304PN2018PTC178826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jeevadravya Bio-Pharma was incorporated on 19 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Jeevadravya Bio-Pharma has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹64 Cr; the latest was in March 2021.
The peers of Jeevadravya Bio-Pharma by revenue are D-Cure Pharmaceuticals Private Limited, Arcetic Life Sciences Private Limited, Metaverse Biotech Tools Private Limited, Rural Surgery Innovations Private Limited, Lepidus Pharma India Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Tushar Vijay Modak ceased to be Additional Director on 15 Dec 2020. Saurabh Lakshman Prabhudesai ceased to be Director on 28 Feb 2020. Tushar Vijay Modak was appointed as Director on 15 Feb 2020. Jeevadravya Bio-Pharma has 4 board changes on record in total.
The registered office of Jeevadravya Bio-Pharma is at 16 – B – 1 Dr. Ambedkar Rd Sarosh Bhawan Office – 10, Pune, Maharashtra, India – 411001.
Jeevadravya Bio-Pharma operates in the pharma industry, in the drug formulation and development segment.
Jeevadravya Bio-Pharma can be reached at its registered office: 16 – B – 1 Dr. Ambedkar Rd Sarosh Bhawan Office – 10, Pune, Maharashtra, India – 411001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
